Details About Generic Salt ::  Natamyci

Main Medicine Class:: Ophthalmic,Anti-infective   

(NAT-uh-MY-sin)
Natacyn
Class: Ophthalmic/Anti-infective

 

Drugs Class ::

 Action Binds to fungal cell membrane, altering membrane permeability and depleting essential cellular constituents.

Indications for Drugs ::

 Indications Treatment of fungal blepharitis, conjunctivitis and keratitis caused by susceptible organisms.

Drug Dose ::

 Route/Dosage

ADULTS: Ophthalmic 1 gtt in conjunctival sac q 1 to 2 hr initially; after 3 to 4 days, frequency of instillation usually reduced to 1 gtt 6 to 8 times daily. Continue for 14 to 21 days or until there is resolution of active fungal keratitis.

Contraindication ::

 Contraindications Standard considerations.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Keratitis: Continue medication for 14 to 21 days or until active fungal keratitis has resolved, to avoid recurrence.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

EENT: Conjunctival chemosis; hyperemia.

Drug Mode of Action ::  

 Action Binds to fungal cell membrane, altering membrane permeability and depleting essential cellular constituents.

Drug Interactions ::

 Interactions

None well documented.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain baseline ophthalmic assessment: Presence of pain, visual changes, signs and symptoms that prompted patient to seek treatment.
  • Assess for ocular inflammation or irritation. Note presence of discharge, including amount and characteristics.
  • Re-evaluate patient regularly for effectiveness of therapy.

Drug Storage/Management ::

 Administration/Storage

  • Administer as topical ophthalmic suspension.
  • Shake well before administering medication.
  • To administer, wash hands thoroughly. Have patient tilt head back. Pull lower eyelid down to create pocket. Place prescribed number of drops in pocket, taking care not to touch eye or allow dropper to touch eye, eyelid or other surfaces. Wash hands again after instillation.
  • Store at room temperature or refrigerate. Do not freeze. Protect from light and excessive heat.

Drug Notes ::

 Patient/Family Education

  • Review proper method of instillation of medication. Instruct patient to clean excessive exudate before instilling drops and to apply light pressure to lacrimal sac for 1 min after drops are instilled.
  • Emphasize importance of thorough handwashing before and after instillation and need to avoid touching eye or allowing dropper to touch eye, lids or other surfaces, to prevent spread of infection to unaffected eye or others.
  • Warn patient to avoid scratching, rubbing, or touching eyes.
  • Instruct patient to consult physician before applying medication while wearing contact lenses.
  • Advise patient to notify physician if no improvement in 7 to 10 days.
  • Instruct patient to report the following symptom to physician: Conjunctivitis (ie, pain, itching, changes in vision and sense of foreign body in eye).

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

We would like to keep you updated with special notifications.